BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2272249)

  • 1. Detection of cells resistant to alkylating agents by flow cytometric analysis of DNA damage.
    Frankfurt OS; Seckinger D; Sugarbaker EV
    Cytometry; 1990; 11(8):894-900. PubMed ID: 2272249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of DNA damage and repair in the cells resistant to alkylating agents.
    Frankfurt OS; Seckinger D; Sugarbaker EV
    Cancer Res; 1990 Aug; 50(15):4453-7. PubMed ID: 2369722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intercellular transfer of drug resistance.
    Frankfurt OS; Seckinger D; Sugarbaker EV
    Cancer Res; 1991 Feb; 51(4):1190-5. PubMed ID: 1997161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased stability of DNA in cells treated with alkylating agents.
    Frankfurt OS
    Exp Cell Res; 1990 Dec; 191(2):181-5. PubMed ID: 2257876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry analysis of DNA damage and the evaluation of cytotoxicity of alkylating agents.
    Frankfurt OS
    Cancer Res; 1987 Nov; 47(21):5537-41. PubMed ID: 3664462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of apoptosis in leukemic and breast cancer cells with monoclonal antibody to single-stranded DNA.
    Frankfurt OS
    Anticancer Res; 1994; 14(5A):1861-9. PubMed ID: 7531415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry analysis of single-strand DNA damage in neuroblastoma cell lines using the F7-26 monoclonal antibody.
    Grigoryan RS; Yang B; Keshelava N; Barnhart JR; Reynolds CP
    Cytometry A; 2007 Nov; 71(11):951-60. PubMed ID: 17879237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of DNA repair in cells treated with a combination of alkylating agents.
    Frankfurt OS; Seckinger D; Sugarbaker EV
    Anticancer Res; 1993; 13(4):947-52. PubMed ID: 8352564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of apoptosis in a heterogenous cell population using flow cytometry.
    Sedlák J; Hunáková L; Duraj J; Suliková M; Chovancová J; Novotný L; Chorváth B
    Gen Physiol Biophys; 1999 Oct; 18 Spec No():147-54. PubMed ID: 10703733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-tube triple staining method for flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation.
    Corver WE; Bonsing BA; Abeln EC; Vlak-Theil PM; Cornelisse CJ; Fleuren GJ
    Cytometry; 1996 Dec; 25(4):358-66. PubMed ID: 8946143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
    Cimoli G; Valenti M; Parodi S; Mazzoni A; De Sessa F; Conte P; Russo P
    Oncol Res; 1993; 5(8):311-23. PubMed ID: 8012063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid and sensitive flow cytometric method for the detection of multidrug-resistant cells.
    Herweijer H; van den Engh G; Nooter K
    Cytometry; 1989 Jul; 10(4):463-8. PubMed ID: 2766891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents.
    Ahmad S; Okine L; Wood R; Aljian J; Vistica DT
    J Cell Physiol; 1987 May; 131(2):240-6. PubMed ID: 2884224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
    Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric screening for selective toxicity to multidrug-resistant cells.
    Frankfurt OS
    J Natl Cancer Inst; 1987 Oct; 79(4):831-6. PubMed ID: 3477663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thaliblastine on cytotoxicity and DNA damage in drug-sensitive and -resistant rat ovarian tumor cells treated with cisplatin.
    Chen G; Zeller WJ
    Anticancer Res; 1993; 13(1):219-23. PubMed ID: 8476216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R
    Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired alkylating drug resistance of a human ovarian carcinoma cell line is unaffected by altered levels of pro- and anti-apoptotic proteins.
    Roy G; Horton JK; Roy R; Denning T; Mitra S; Boldogh I
    Oncogene; 2000 Jan; 19(1):141-50. PubMed ID: 10644989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous flow cytometric analysis of two cell surface markers, telomere length, and DNA content.
    Schmid I; Dagarag MD; Hausner MA; Matud JL; Just T; Effros RB; Jamieson BD
    Cytometry; 2002 Nov; 49(3):96-105. PubMed ID: 12442309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.